Clinical trials
Phase 3 Macular Degeneration trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 4 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 3 |
| OccuLogix | 2 |
| Ophthotech Corporation | 2 |
| 4D Molecular Therapeutics | 1 |
| AbbVie | 1 |
| Allergan | 1 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
| IVERIC bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 18 |
| Choroidal Neovascularization | 5 |
| Geographic Atrophy | 4 |
| Wet Macular Degeneration | 4 |
| Eye Diseases | 3 |
| Retinal Degeneration | 3 |
| Retinal Diseases | 3 |
| Vision Disorders | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.